Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...

Under healthy conditions, the intestinal epithelium fully renews itself every three to five days. Aging and exposure to ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells ...

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...

An international research team has succeeded in deciphering a key mechanism that controls the growth of pancreatic cancers. The scientists identified a potential central mechanism by which cancer ...

Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) were recently ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

Researchers at UCLA have developed a powerful new weapon in the battle against kidney cancer. Instead of relying on treatments tailored to each patient, this innovation uses specially engineered ...

Colorectal cancer, the abnormal growth of cancerous cells in the large intestine or the rectum, is one of the most common ...

New melanoma immunotherapy research reveals how changing the way tumors die can awaken immune defenses and improve outcomes in mice.